These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10935239)

  • 61. Increased seizures after discontinuing carbamazepine: results from the gabapentin monotherapy trial.
    DeToledo JC; Ramsay RE; Lowe MR; Greiner M; Garofalo EA
    Ther Drug Monit; 2000 Dec; 22(6):753-6. PubMed ID: 11128246
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Conversion from thrice daily to twice daily administration of gabapentin (GBP) in partial epilepsy: analysis of clinical efficacy and plasma levels.
    Muscas GC; Chiroli S; Luceri F; Mastio MD; Balestrieri F; Arnetoli G
    Seizure; 2000 Jan; 9(1):47-50. PubMed ID: 10667963
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Aggravation of focal epileptic seizures by antiepileptic drugs.
    Elger CE; Bauer J; Scherrmann J; Widman G
    Epilepsia; 1998; 39 Suppl 3():S15-8. PubMed ID: 9593231
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The efficacy of gabapentin in children of partial seizures and the blood levels.
    Nonoda Y; Iwasaki T; Ishii M
    Brain Dev; 2014 Mar; 36(3):194-202. PubMed ID: 23647918
    [TBL] [Abstract][Full Text] [Related]  

  • 65. New antiepileptic drugs for children: felbamate, gabapentin, lamotrigine, and vigabatrin.
    Devinsky O; Vazquez B; Luciano D
    J Child Neurol; 1994 Oct; 9 Suppl 1():S33-45. PubMed ID: 7822751
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Drug treatment of benign focal epilepsies of childhood.
    Bourgeois BF
    Epilepsia; 2000 Aug; 41(8):1057-8. PubMed ID: 10961639
    [No Abstract]   [Full Text] [Related]  

  • 67. Dosing to efficacy with neurontin: the STEPS trial. Study of Titration to Effect Profile of Safety.
    Morrell MJ
    Epilepsia; 1999; 40 Suppl 6():S23-6; discussion S73-4. PubMed ID: 10530679
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Isolated ataxia as an idiosyncratic side-effect under gabapentin.
    Steinhoff BJ; Herrendorf G; Bittermann HJ; Kurth C
    Seizure; 1997 Dec; 6(6):503-4. PubMed ID: 9530950
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gabapentin in the treatment of refractory partial epilepsy in children with intellectual disability.
    Mikati MA; Choueri R; Khurana DS; Riviello J; Helmers S; Holmes G
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():57-62. PubMed ID: 10030434
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serum concentrations and effects of gabapentin and vigabatrin: observations from a dose titration study.
    Lindberger M; Luhr O; Johannessen SI; Larsson S; Tomson T
    Ther Drug Monit; 2003 Aug; 25(4):457-62. PubMed ID: 12883229
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
    McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
    Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy and tolerability of gabapentin in clinical practice.
    Morris GL
    Clin Ther; 1995; 17(5):891-900. PubMed ID: 8595641
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gabapentin toxicity in children manifesting as behavioral changes.
    Wolf SM; Shinnar S; Kang H; Gil KB; Moshé SL
    Epilepsia; 1995 Dec; 36(12):1203-5. PubMed ID: 7489697
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Selected CSF biochemistry and gabapentin concentrations in the CSF and plasma in patients with partial seizures after a single oral dose of gabapentin.
    Ben-Menachem E; Persson LI; Hedner T
    Epilepsy Res; 1992 Mar; 11(1):45-9. PubMed ID: 1373372
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Gabapentin--a new antiepileptic agent].
    Nakken KO; Rytter E; Johannessen SI
    Tidsskr Nor Laegeforen; 1998 Feb; 118(6):872-4. PubMed ID: 9543799
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gabapentin dosing in the treatment of epilepsy.
    McLean MJ; Gidal BE
    Clin Ther; 2003 May; 25(5):1382-406. PubMed ID: 12867216
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A postmarketing surveillance study of gabapentin as add-on therapy for 3,100 patients in England.
    Wilton LV; Shakir S
    Epilepsia; 2002 Sep; 43(9):983-92. PubMed ID: 12199723
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gabapentin-induced mood changes with hypomanic features in adults.
    Trinka E; Niedermüller U; Thaler C; Doering S; Moroder T; Ladurner G; Bauer G
    Seizure; 2000 Oct; 9(7):505-8. PubMed ID: 11034877
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gabapentin in late-onset poststroke seizures.
    Alvarez-Sabín J; Montaner J; Padró L; Molina CA; Rovira R; Codina A; Quintana M
    Neurology; 2002 Dec; 59(12):1991-3. PubMed ID: 12499501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.